Alan D. Roth

Alan’s career in life sciences comprises basic research, investment management/capital markets, strategic consultancy and emerging company operations. Starting his career as a chemist at Merck & Co., Inc. in New Lead Discovery, after his academic work he joined McKinsey serving leading companies in a variety of industries. He subsequently became Director at Commerzbank Asset Management ($140bn AUM) in London and Frankfurt in charge of global equity bio-investments as well as overall industrial investment research.

He co-founded, took public and was first CEO and CFO of Chiral Quest, Inc., a life sciences company in the area of chiral pharmaceuticals. Alan earned his BA (Hons) from Cornell University, PhD from Columbia University, and Postdoctoral Fellowship in from the University of Oxford in organic chemistry. He also serves as Director in Fitzroy Partners in London developing new health sciences ventures internationally. At the University of Oxford, he is Royal Society Entrepreneur in Residence and Visiting Lecturer in the area of science entrepreneurship.